Related references
Note: Only part of the references are listed.Autophagy controls programmed death-ligand 1 expression on cancer cells (Review)
Lijuan Gao et al.
BIOMEDICAL REPORTS (2021)
Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies
Yuchen Wang et al.
BIOMATERIALS (2021)
Pembrolizumab plus chemotherapy in triple-negative breast cancer
Jun Masuda et al.
LANCET (2021)
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease
G. A. Horne et al.
LEUKEMIA (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Florence Coussy et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Breast Cancer, Version 3.2020
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
Barbara Schroers et al.
FRONTIERS IN ONCOLOGY (2020)
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
Ying Ji et al.
NATURE COMMUNICATIONS (2020)
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Jingjing Liang et al.
SCIENCE ADVANCES (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Xiaojuan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion
Irmina A. Elliott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D. Mayer et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy
Quan Zhou et al.
NATURE NANOTECHNOLOGY (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Assemblies of Peptide-Cytotoxin Conjugates for Tumor-Homing Chemotherapy
Jinqiang Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss et al.
CLINICAL CANCER RESEARCH (2019)
Polymer-drug conjugate therapeutics: advances, insights and prospects
Iriny Ekladious et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Selective Autophagy Regulates Cell Cycle in Cancer Therapy
Kai Zheng et al.
THERANOSTICS (2019)
Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1
Christina M. Maher et al.
MOLECULAR CANCER RESEARCH (2018)
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
Mario Mauthe et al.
AUTOPHAGY (2018)
A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy
Wei Shen et al.
BIOMATERIALS (2018)
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Femke M. de Man et al.
CLINICAL PHARMACOKINETICS (2018)
The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer
Dongfang Tang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Mechanism and medical implications of mammalian autophagy
Ivan Dikic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells
Sarmistha Talukdar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Camptothecin induces G2/M phase arrest through the ATM-Chk2-Cdc25C axis as a result of autophagy-induced cytoprotection: Implications of reactive oxygen species
Rajapaksha Gedara Prasad Tharanga Jayaso et al.
Oncotarget (2018)
Micelles with ultralow critical micelle concentration as carriers for drug delivery
Yang Lu et al.
NATURE BIOMEDICAL ENGINEERING (2018)
The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells
Naoise C. Synnott et al.
TRANSLATIONAL ONCOLOGY (2018)
Chloroquine induces lysosomal membrane permeability-mediated cell death in bladder cancer cells
Hung-En Chen et al.
FORMOSAN JOURNAL OF SURGERY (2018)
Autophagy in cancer metastasis
E. E. Mowers et al.
ONCOGENE (2017)
CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk
Pinjia Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
The Interconnections between Autophagy and Integrin-Mediated Cell Adhesion
Ariadne Vlahakis et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Repair, Reuse, Recycle: The Expanding Role of Autophagy in Genome Maintenance
Graeme Hewitt et al.
TRENDS IN CELL BIOLOGY (2017)
Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy
Marina Santiago Franco et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents
Ciska Verbaanderd et al.
ECANCERMEDICALSCIENCE (2017)
Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery
Xin Liu et al.
ADVANCED MATERIALS (2016)
SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair
Graeme Hewitt et al.
AUTOPHAGY (2016)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Loss of autophagy causes a synthetic lethal deficiency in DNA repair
Emma Y. Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Topoisomerase-mediated chromosomal break repair: an emerging player in many games
Mohamed E. Ashour et al.
NATURE REVIEWS CANCER (2015)
Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
Lei Miao et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine
Paola Pellegrini et al.
AUTOPHAGY (2014)
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
Myrna R. Rosenfeld et al.
AUTOPHAGY (2014)
A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
Longyan Liao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
OPINION Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression
Cassandra L. Buchheit et al.
NATURE REVIEWS CANCER (2014)
Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells
Yuan-Fei Peng et al.
AUTOPHAGY (2013)
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
Amelie Petitprez et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Autophagy-dependent senescence in response to DNA damage and chronic apoptotic stress
Kamini Singh et al.
AUTOPHAGY (2012)
MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy
Salome Paillas et al.
AUTOPHAGY (2012)
Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency
Quentin McAfee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Suppression of Autophagy by FIP200 Deletion Impairs DNA Damage Repair and Increases Cell Death upon Treatments with Anticancer Agents
Heekyong Bae et al.
MOLECULAR CANCER RESEARCH (2011)
Autophagy Is Activated by TGF-β and Potentiates TGF-β-Mediated Growth Inhibition in Human Hepatocellular Carcinoma Cells
Kunihiko Kiyono et al.
CANCER RESEARCH (2009)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Min Huang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3
Shunsuke Kimura et al.
AUTOPHAGY (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells
M. Katayama et al.
CELL DEATH AND DIFFERENTIATION (2007)
CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo
Archie N. Tse et al.
CLINICAL CANCER RESEARCH (2007)
Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice
Lawrence D. Mayer et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Chk1 is essential for tumor cell viability following activation of the replication checkpoint
SH Cho et al.
CELL CYCLE (2005)
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Y Xu et al.
ANNALS OF ONCOLOGY (2002)
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
RI Yarden et al.
NATURE GENETICS (2002)
Share Paper
